TAYLOR BINKLEY
Family Nurse Practitioner · PLANO, TX
Individual Active NPI 1447980842
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 509 | 135,998 | $12,253,255 | $3,493,688 | $2,778,067 |
| 2023 | 280 | 44,122 | $4,148,123 | $1,209,237 | $963,239 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 24,400 | $1 | $1 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 13,950 | $1 | $1 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 9,030 | $10 | $8 |
| J0897 | Injection, denosumab, 1 mg | 8,820 | $25 | $20 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 7,980 | $18 | $14 |
| J1756 | Injection, iron sucrose, 1 mg | 6,600 | $0 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,500 | $12 | $9 |
| J2357 | Injection, omalizumab, 5 mg | 3,000 | $38 | $30 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,384 | $44 | $35 |
| J3245 | Injection, tildrakizumab, 1 mg | 1,400 | $136 | $108 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,010 | $31 | $25 |
| J0517 | Injection, benralizumab, 1 mg | 930 | $154 | $123 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 1084709 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1427534205
- NPI 1508307679
- NPI 1891336020
- NPI 1669835708
- NPI 1386587707
- NPI 1992135909
- NPI 1093155038
- NPI 1528873809
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.